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Diabetes Mellitus may lead to alterations in the eyes,
kidneys, cranial nerves, peripheral nerves, ears etc. The
cognitive function also seems to be compromised in subjects
presented with Diabetes Mellitus, since the cortical and
subcortical structures responsible for this function are
hindered in some insulin-dependent patients. The cognitive
potential P300 has been used as an objective procedure to
assess cerebral cognitive functions. Aim: To analyze the
sensitivity of P300 cognitive potential for the detection of
alterations on the auditory cortex secondary to Diabetes
Mellitus. Study design: transversal cohort. Material and
Method: Sixteen diabetic subjects of both genders aged 7
to 71 years, and seventeen non-diabetic individuals at the
same age range participated in this study. The evaluation
procedures were pure tone audiometry (PTA) and P300
cognitive potential. Glycemia of the group presented with
Diabetes was assessed prior to applying P300. Results: No
statistically significant difference was shown for PTA results.
A statically significant difference was observed between
groups when analyzing the latency of P300 component
measured in Fz. There was a correlation between glycemia
and latency and amplitude of P300. Conclusion: The
investigation of the cognitive potential of P300 is an important
procedure for prevention and early diagnosis of neurological
changes in individuals presented with Diabetes Mellitus.
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INTRODUCTION
Diabetes mellitus is a chronic condition whose onset
is given when the pancreas does not produce enough amount
of insulin or when the body does not manage to effectively
use the produced insulin. Abnormalities to production and/
or action of insulin may take to hyperglycemia. Prevalence
of diabetes varies a lot in all different regions of the world
and within the same regions, and we expect that by 2025,
the population of diabetic patients in the world will double
when compared to the number of existing diabetic patients
in 2000 (150 million to 300 million). Diabetes Mellitus is the
most prevalent chronic-degenerative disease in our days.
There are four main types of diabetes: 1) type 1 -
there is autoimmune destruction of pancreas beta cells that
lead to inability to produce insulin, requiring insulin injections
to ensure survival of patients; 2) type 2 - it is characterized
by affections to action and production of insulin and there
may be predominance of one situation over the other, and
normally both of them are present. Metabolic control is
normally obtained with diet, physical exercises and/or
concomitant use of oral hypoglycemic agents, and insulin
may be used for treatment; 3) secondary diabetes - type of
diabetes in which the causal factor is known, such as some
genetic defects that result in abnormalities of beta cell
function or insulin action, some pancreatic and endocrine
diseases, or those caused by some drugs; 4) gestational dia-
betes - it is primarily diagnosed during pregnancy and it
may disappear at the end of the pregnancy period.
In chronic complications of Diabetes Mellitus there
may be presence of eye, kidney, cranial nerves, peripheral
nerves and ear affections. In the hearing system, there may
be atrophy of spiral ganglion, degeneration of myelin sheath
of the eighth cranial nerve, reduction of the number of
nervous fibers on spiral lamina, or thickness of capillary wall
of vascular stria and of small arteries inside the auditory ca-
nal 1. In histology, inner ear affections are found in 50% of
the people with diagnosis of Diabetes Mellitus 2.
The hearing loss detected in subjects with diabetes
mellitus is characterized as bilateral, symmetrical sensorineural
loss more marked in high frequencies 3, 4. However, it has
been observed that in diabetes type 1, the occurrence of
hearing loss is associated with age, duration of disease and
presence of neuropathy 5, 6.
Cognitive function may also seem to be affected in
subjects with diabetes mellitus, given that cortical and
subcortical structures responsible for this function are altered
in some insulin-dependent patients 7.
Cognitive P300 potential has been used as an objective
procedures to assess cerebral cognitive function, and it seems
to be the right tool to check sequelae caused by hypoglycemia
in the hippocampus region 8, 9. In general, we can observe
increased latency of cognitive potential P300 both in subjects
with diabetes mellitus types 1 and 2 10, 11, and in diabetes
type 2 this fact may take place when there are no clinical
signs of nervous system damage 12. P300 cognitive potential
is discussed as the most sensitive potential to detect subclinical
effects of acute hypoglycemia, when compared to
psychometric tests and electroencephalogram 13.
Studies demonstrated significant correlation between
P300 cognitive potential latency and duration of diabetes
mellitus, and even though they did not observe it when
analyzing the number of episodes of hypoglycemic coma. It
indicates that in the evolution of glycemia impairment, long
term metabolic abnormalities are more relevant than isolated
episodes of hypoglycemia 14. Prolonged hypoglycemia may
cause permanent damage to the brain, especially in insulin-
dependent diabetic children 15.
Thus, the purpose of the present study was to analyze
sensitivity of P300 potential to detect cognitive function
affections in subjects with diabetes mellitus.
MATERIAL AND METHOD
The present study was conducted at Audiological
Research Center (CPA), Hospital de Reabilitação de Anoma-
lias Craniofaciais e Clínica de Fonoaudiologia, Dental Science
School, Bauru, University of Sao Paulo, campus Bauru – SP.
Selection of Sample
Subjects were referred by the endocrinologist of
Diabetic Association of Bauru/Sao Paulo. The inclusion
criterion was previous diagnosis of diabetes mellitus. The
control group was matched by gender, age and grade of
hearing loss to exclude these variables from the exam
analysis. In both groups, we excluded the following cases:
• history of other risk factors for hearing loss and/or
conventional assessment that presented conductive
hearing loss, confirmed by acoustic immittance
measurement;
• presence of non-auditory associated disorders that could
lead to long-latency potentials, such as neurological
diseases or syndromes.
We did not exclude subjects with hearing loss, given
that auditory evoked event-related potentials suffer more
influence of factors such as motivation of subjects to conduct
the test, attention to stimuli, and level of difference between
presented stimuli.
Material
The study comprised 33 subjects and 16 had diagnosis
of diabetes mellitus, both genders and ages ranging from 7
to 71 years (diabetic group) and 17 non-diabetic patients
matched by gender, age and hearing loss (control group).
All subjects received a letter of information and signed the
informed consent term to participate in the study.
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Process of Assessment
Pure tone audiometry
Pure tone audiometry (PTA) was conducted in
soundproof booth, audiometer Madsen, model Midmate 622,
earphones TDH-39, calibrated according to ANSI-69. We
investigated pure tone thresholds in frequencies 0.5 to 8
kHz by air conduction, being considered normal ≤ 25 dB
HL.
Cognitive P300 Potential
Auditory evoked potentials refer to changes in
electrical activity that occur in the peripheral and central
auditory systems in view of an acoustic or electrical stimulus.
Evoked potential of the brain is a response to an internal
event, such as perception or cognition, and it is named
event-related potential, also considered an endogenous
potential. In this category, we can include cognitive P300
potential.
Cognitive P300 potential occurs in subjects that
consciously recognize the presence of an acoustic stimulus
presented by tone burst or speech. Thus, to record P300,
we use oddball paradigm, which is characterized by random
presentations of stimulus, considered as rare during the
presentation of another frequent stimulus. In case of the
use of tone burst, stimuli differ concerning frequency, intensity
and duration.
In this study, the investigation of P300 cognitive
potential was performed in a silent room using insertion
phones 3A. We used disposal electrodes for ECG AG/AGCL
with gel and clamp type wires to allow the use of this
electrode. To start electrophysiological assessment, it was
necessary to have electrodes with individual impedance
below 5KΩ and impedance between them below 2KΩ. The
test was conducted with subjects lying down comfortably
and with closed eyes (elimination of artifact caused by ocu-
lar movement). Active electrodes were placed in Cz and Fz
and connected to input 1 of channels 1 and 2, respectively,
of pre-amplifier. Reference electrodes were placed on right
and left mastoid and connected to input 2 of channels 1 and
2 of the pre-amplifiers and the ground electrode was place
on position Fpz.
We used tone burst stimuli in frequency of 2kHz for
rare stimulus, presented randomly in likelihood of 20%, mixed
with frequent tone burst of 1kHz, presenting likelihood of
80%, with 25ms rise and 50ms plateau, moderate intensity
of 70dB, speed of 1 stimulus every second and use of pass
filter 1 to 125Hz. Initial registration was filtered with low-
pass digital filter for cut-off frequency of 25Hz. The subjects
were asked to identify the rare stimulus, counting in loud
voice.
To search for the cognitive potential P300 we used
the device Biologic’s Evoked Potential System (EP).
Glucose levels were measured in all diabetic patients
after placement of electrodes and insertion phones before
P300. To that end, we used device Advantage, Accu-check
Product, Roche, with Advantage, glucose tape.
Parameters of results’ analyses
Out of the total data collected, the important figures
were pure tone thresholds for right and left ears measured
by air conduction in frequencies of 0.5 to 8kHz and absolute
latency of components N2 and P300 and amplitude (amp)
of P300, recorded in Fz and Cz. We considered as presence
of P300 wave when it was simultaneously recorded in Fz
and Cz.
Statistical analysis
The results of pure tone audiometry were analyzed
by descriptive analysis to calculate mean, standard deviation,
χ2 test to compare control and diabetic groups, analysis of
variance with repetitive measurements considering both right
and left sides and control and diabetic groups. Results of
P300 potential were also analyzed with descriptive analysis
to calculate mean and standard deviation, Student t test to
compare absolute latency of components N2 and P300 and
amplitude, measured in Cz and Fz, for control group and
diabetics, and Pearson correlation to check correlation
between glucose level and absolute latency of components
N2 and P300 and P300 amplitude, measured in Cz and Fz,
respectively.
RESULTS
In Table 1, we show occurrence of hearing loss seen
in pure tone audiometry and the results of χ2 test comparing
control and diabetic groups, showing that there were no
statistically significant differences between them.
In table 2, we show the results of the statistical analysis
to compare control and diabetic groups using Variance
Analysis in repetitive measurements, whose factors were
tested and analyzed in groups, plus auditory thresholds
obtained in PTA for each tested frequency.
Distribution of subjects in the control and diabetic
groups, according to level of hearing loss detected in pure
tone audiometry, considering means of auditory thresholds
in 0.5, 1 and 2 kHz are found in Table 3. In the same table,
we found results of χ2 test by comparing control and diabetic
groups.
Table 4 presents descriptive statistical analysis of P300
and absolute latencies of components N2 and P300, in ms,
and amplitude of P300 recorded in Fz and Cz.
Table 5 presents results of the statistical analysis
comparing control and diabetic groups using t Student test
and absolute latency of components N2 and P300 in ms and
amplitude of P300 recorded in Fz and Cz, respectively.
The correlations between glucose level collected
before the study of P300 and components N2Cz, N2Fz,
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P300Cz and P300Fz, P300Cz amp, P300Fz amp, using
Pearson correlation test are described in Table 6.
Graphs 1, 2 and 3 show the correlation between
component FzP300, considering latency and amplitude of
glucose level, respectively.
DISCUSSION
The fact that there were no statistically significant
differences between control and diabetic groups concerning
occurrence of hearing loss (Table 1) may be justified by age
range of the studied group - seven to 72 years in the control
group and seven to 71 years in the diabetic group, counting
on the influence of aging in both groups 1. It is important to
point out that all subjects with hearing loss, both in the control
and diabetic groups, presented age older than 35 years.
The comparative analysis of hearing thresholds
obtained for each tested frequency in pure tone audiometry
did not show statistically significant differences between the
groups (Table 2). It is was possible to detect similarity in
the configuration of audiometric curves in control and diabetic
patients, and low sounds had auditory thresholds more
preserved than high frequencies, characterizing descending
audiometric curve in both groups. This type of configuration
is common both in auditory loss resulting from aging and in
diabetes mellitus, owing to initial affection to the cochlea
base, region responsible for high frequencies. Our findings
are in accordance with previous studies 2-5. Similar results
were observed when we considered the classification of
hearing loss according to mean frequencies of 0.5, 1 and 2
kHz. Our findings are in accordance with the results of
previous studies 4,5.
As to P300 cognitive potential, we recorded
components N2 and P300 in all subjects of the control group
and diabetic group.
Upon investigating P300, we observed increased
latency of P300 in Cz, presenting value of 324.55 ± 37.47
ms in the control group and 355.07± 41.31 ms in the diabetic
group, with statistically significant difference (Tables 4 and
5). We did not detect statistically significant difference
between groups when we analyzed N2 in Cz and Fz. These
results suggest increase in latency of P300 in diabetic patients,
reflecting possible affections to attention process, auditory
discrimination, memory and semantic perspective of these
subjects. In the literature, some studies with auditory evoked
potentials demonstrated affection to P300 in diabetic patients
6, 7; however, others did not find the same abnormality 8.
According to Pearson correlation test, there was
statistically significant correlation between latency of
components FZN2 (p=0.027) and CZP3 (p=0.043) and
amplitude of component FZP3 amp (p=0.009) with level
of blood glucose. However, we did not observe the same
component FZP3 (p=0.141), CZN2 (p=0.083) and CZP3 amp
(p=0.283) (Table 6 and Graphs 1, 2 and 3).
Table 1. Distribution of subjects in the control and diabetic
groups according to presence or absence of hearing loss
detected with pure tone audiometry. Result of χ2 test comparing
control and diabetic patients.
PURE TONE AUDIOMETRY
NORMAL  HEARING LOSS
n % n %
Control 6 35 11 65
Diabetic 5 31 11 69
TOTAL 11 33 22 67
χ2 0.881
*p<0.005 – statistically significant difference.
Table 2. Statistical Analysis to compare control and diabetic
groups using Variance Analysis (repetitive measures with
repetition factor side and repetition factor group) concerning
pure tone thresholds for each tested frequency.
0.5 1 2 3 4 6 8 KHz
Control x
Diabetic (p) 0.212 0.201 0.262 0.235 0.499 0.424 0.604
p≤0.05 – statistically significant difference.
Table 3. Distribution of subjects in control and diabetic groups
according to presence or absence of hearing loss detected in
pure tone audiometry considering mean of auditory thresholds
in 0.5, 1 and 2 kHz. Result of the test χ2 comparing control and
diabetic group.
PURE TONE AUDIOMETRY – hearing loss
Control x Diabetic (p) 0,1
p≤0.05 – statistically significant difference.
Table 4. Descriptive statistical analysis of P300 cognitive
potential concerning absolute latency of components N2
and P300, in ms, and amplitude of P300 recorded in Fz and
Cz.
P300 COGNITIVE POTENTIAL
CONTROL DIABETIC
X SD X SD
CzN2 229.31 14.61 232.38 28.55
CzP300 324.55 37.47 355.07 41.31
CzP300-amp 2.84 2.99 1.91 1.08
FzN2 232.49 12.7 234.40 31.79
FzP300 333.55 26.28 350.95 41.15
FzP300-amp 3.27 4.35 1.98 0.85
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Results demonstrated that reduction of glucose
level in diabetic subjects takes to increase in latency
and reduction of amplitude of component P300,
suggesting that there is central auditory system
dysfunction. Considering that nervous tissue is glucose-
dependent, that is, it depends on stable glucose levels
in ideal situations, episodes of hypoglycemia for
prolonged periods of time may take the subject to
significant neurological affections 9.
Thus, the investigation of P300 cognitive potential
may be an important procedure for prevention and early
diagnosis of neurological affections in subjects with Diabe-
tes Mellitus10,11.
It is important to highlight that normally in these
studies conducted with diabetes type 1 patients, differently
from the present study, in which most of the population
was comprised by type 2 diabetes patients, we demonstrated
that hearing affection may occur in both types of diabetes
mellitus.
Table 5. Statistical analysis to compare control and diabetic
groups with t Student test concerning absolute latency of
components N2 and P300, in ms, and amplitude of P300
recorded in Fz and Cz, respectively.
P300 COGNITIVE POTENTIAL
FzN2 FzP300 FzP300 CzN2 CzP300 CzP300
amp amp
Control x
Diabetic 0.82 0.15 0.25 0.69 0.03 * 0.25
* p< 0.05 – statistically significant difference.
Table 6. Correlation between glucose level collected in diabetic
groups before the study of P300 cognitive potential and
components N2Cz, N2Fz, P300Cz and P300Fz, P300Cz amp,
P300Fz amp, using Pearson correlation test.
STATISTICAL ANALYSIS –Pearson Correlation
FzN2 FzP300 FzP300 CzN2 CzP300 CzP300
amp amp
p 0.027 * 0.141 0.009 * 0.083 0.043 * 0.283
* p< 0.05 – statistically significant difference.
Graph 1. Correlation between latency FZN2 (ms) and glucose level
(mg/dl).
Graph 2. Correlation between latency of CZP3 (ms) and glucose
level (mg/dl).
Graph 3. Correlation between amplitude of FZP300 (¼v) and glucose
level (mg/dl).
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CONCLUSION
The results obtained with the present study allowed
the conclusion that P300 cognitive potential investigation is
an important procedure to prevent and early diagnose
neurological affections in subjects with Diabetes Mellitus
types 1 and 2.
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